Ultimate Anti-Snoring Solutions Guide 2026: 12 Methods Tested and Ranked

Snoring affects roughly four in ten European adults at least occasionally, and habitually disrupts sleep for around one in five, according to the European Respiratory Society. The good news in 2026: the toolkit for stopping it has never been broader, cheaper, or better validated. From €4 nasal strips you can use tonight, all the way to €25,000 maxillofacial surgery, the right answer depends on your snoring type, severity, anatomy, age, weight, and tolerance for nightly maintenance. This guide ranks the 12 most evidence-backed options, side by side, for European readers across France, Germany, Spain, Italy, the Netherlands, the UK, Belgium, Austria, Switzerland, Portugal, Ireland, the Nordic countries, and Eastern Europe. If you are new to the topic, start with our overview of why people snore before choosing any method.

We pulled data from EU clinical trials, ENT consensus statements, the European Respiratory Society, the European Academy of Sleep Medicine, AASM guidelines, and real-world EU clinic adherence studies. We weighted ease of use, evidence strength, EU price in euros, and time to effect. Where the literature is thin — smart beds, app-based programs, novelty pillows — we say so plainly. Where it is robust — CPAP, mandibular advancement devices, hypoglossal stimulation, weight loss — we explain why too. We will introduce a low-friction option, the Back2Sleep nasal stent, in its proper place: a €39 CE-certified Class I device for snoring and mild-to-moderate obstructive sleep apnea (OSA) when nasal collapse is part of the picture. It is not a CPAP replacement for severe disease, and we will say where it does and does not fit.

This is not a sponsored review or a one-size-fits-all top-ten list. The 12 methods below are placed on a hierarchy that reflects evidence strength and breadth of use, not commercial relationships. Our goal is for the reader to leave with a clear plan: what to try first based on their specific snoring pattern, what to escalate to if the first step does not work, and what to avoid because the evidence is weak.

Why snoring matters beyond annoyance

Snoring is often dismissed as a social or relationship problem. The clinical view is more nuanced. Habitual loud snoring is a marker for upper-airway resistance and, in roughly 40 to 50 percent of habitual snorers, undiagnosed obstructive sleep apnoea (OSA). The European Respiratory Journal's 2023 consensus on screening highlights that untreated OSA roughly doubles the risk of hypertension and increases stroke and cardiovascular event risk meaningfully across decades.

Even isolated primary snoring without OSA carries health and lifestyle costs. It fragments your partner's sleep, raising their cardiovascular risk indirectly. It correlates with daytime sleepiness, lower work productivity, and higher accident risk. A 2024 Marseille public-health study estimated annual EU productivity losses from snoring-related sleep disruption in the tens of billions of euros. So while we will not dramatize the danger, treating snoring is a defensible health investment, not just a comfort upgrade.

When snoring is medically urgent

• Witnessed pauses in breathing reported by your partner.
• Daytime sleepiness severe enough to risk driving, machinery, or work.
• Morning headaches, dry mouth, sore throat most days.
• Hypertension that resists medication.
• Recent unexplained weight gain plus new or louder snoring.

If any of these apply, request a sleep study before purchasing a device. Most EU public health systems offer home sleep apnoea testing or in-lab polysomnography for patients meeting screening criteria. The result tells you whether you need full OSA therapy or whether a snoring-only intervention is sufficient.

Why most anti-snoring "tests and rankings" online are misleading

Most ranking articles list devices in random order, citing user reviews instead of trial data. This is misleading because snoring is not one problem. It can come from nasal valve collapse, tongue-base obstruction, soft-palate flutter, jaw retrusion, weight gain, alcohol, or any combination. A device that fixes one cause will fail completely on another.

European ENT consensus, including positions from the European Rhinologic Society and the German Society for Sleep Medicine (DGSM), recommends matching the device to the obstruction site. We ranked the 12 methods below using a transparent rubric: evidence strength (peer-reviewed EU/international trials), AHI or snoring index reduction, adherence at 6 months, EU price in euros, time to first effect, and reversibility. Then we mapped each to the specific snoring cause it solves. That is how you get a fair comparison instead of a popularity contest.

How we ranked: the 6 criteria

• Evidence strength. Number and quality of randomized trials in adults.
• Effect size. Mean AHI reduction or snoring decibel reduction reported.
• Adherence. Percentage of users still using the device at 6 months.
• Price (EU). Direct retail or out-of-pocket cost in euros, no insurance.
• Time to effect. Same night, days, weeks, or months.
• Reversibility. Can you stop without permanent change to anatomy?

Five common snoring patterns, briefly

Before choosing a device, ask which pattern fits you. A partner's recordings or a free smartphone snore-tracking app can help.

• Nasal-collapse snorer. Mouth-breathing, blocked nose at night, snoring louder when supine.
• Tongue-base snorer. Snoring with reduced jaw advancement, often with a small chin or jaw retrusion.
• Soft-palate flutter. Classic flapping vibration sound, often worse with alcohol.
• Positional snorer. Loud only when sleeping on the back, quiet on the side.
• Weight-driven snorer. Snoring started or got worse after weight gain, BMI 28+.

Many people are mixed — partial nasal collapse plus alcohol-driven palate flutter is common. The 12 methods below are mapped to these patterns so you can see at a glance which ones target your specific cause.

Master comparison: the 12 anti-snoring methods at a glance

Below we go deep into each, with EU-relevant context: where you can buy them, what regulators say, what adherence looks like in real European clinics, and which type of snorer benefits most.

1. CPAP therapy: the clinical gold standard for OSA

Continuous Positive Airway Pressure (CPAP) is the most effective treatment for moderate-to-severe obstructive sleep apnea, full stop. A 2023 Cochrane review confirmed CPAP reduces AHI by 80 to 90 percent in adherent users and is the only therapy with mortality reduction evidence at scale. In the EU, ResMed AirSense 11, Philips DreamStation 2, Löwenstein prisma, and Fisher and Paykel Sleepstyle are the dominant machines.

EU patients with diagnosed moderate or severe OSA generally have CPAP funded by their national health system: Sécurité Sociale + Mutuelle in France, GKV/PKV in Germany, NHS in the UK, SSN in Italy, Seguridad Social in Spain, Zorgverzekering in the Netherlands, INAMI in Belgium. For mild OSA or pure snoring, CPAP is usually self-funded and over-engineered. Adherence remains the weak point: roughly 40 to 60 percent of CPAP starters quit within 12 months according to European compliance data, often citing mask discomfort and noise.

Auto-CPAP, BiPAP, and hybrid options in 2026

Modern EU prescriptions increasingly use auto-titrating CPAP machines (APAP), which adjust pressure dynamically through the night. Adherence is moderately better with APAP than fixed-pressure devices. BiPAP (bilevel pressure) is reserved for high-pressure needs or restrictive lung disease overlap. Heated humidification, mask fit clinics, and tele-monitoring through manufacturer cloud platforms (ResMed AirView, Philips Care Orchestrator) have improved long-term adherence in trials by 5 to 15 percentage points across EU sleep services.

If you have started CPAP and struggle with the mask, do not quit silently. Most EU sleep services offer a fitting clinic and will switch from full-face to nasal pillow or hybrid masks. If you remain CPAP-intolerant after 3 to 6 months of effort, mandibular advancement, hypoglossal stimulation, or — for the right anatomy — a nasal stent are reasonable next steps to discuss.

2. Mandibular advancement devices (MAD): the dentist-fitted option

Mandibular advancement devices are dental appliances that pull the lower jaw forward 3 to 8 mm during sleep, opening the airway behind the tongue. The European Sleep Research Society endorses MADs as first-line treatment for primary snoring and mild-to-moderate OSA, particularly when the obstruction is at the tongue base. SomnoDent (Australian, sold widely in EU), Narval (ResMed), and Orthoapnea are common custom-fitted models.

Effect size is meaningful: a 2024 EU multi-centre trial reported a 50 percent average AHI reduction in mild-moderate OSA. Adherence is better than CPAP, around 70 percent at 12 months. The catch is cost and fitting: custom MADs in the EU run €1,200 to €2,000 with a sleep dentist, with some partial reimbursement under French Mutuelle, German PKV, or Belgian INAMI for diagnosed OSA. Boil-and-bite versions cost €80 to €150 but fit poorly and risk tooth and jaw discomfort.

Boil-and-bite vs custom MAD

Off-the-shelf, boil-and-bite mandibular devices sold over the counter for €80 to €150 are tempting but underperform. EU dental sleep medicine surveys repeatedly show that custom-fitted MADs deliver larger AHI reductions, better long-term comfort, and significantly lower drop-out rates after 6 months. Boil-and-bite versions can also cause progressive bite changes when used nightly for years. They are reasonable as a 2-week diagnostic — does jaw advancement help your snoring? — before investing in a custom version through a sleep dentist.

Sleep dentistry is more developed in some EU countries than others. Germany, the Netherlands, and the UK have established dental sleep medicine networks. France via SFRMS and Italy via AIMS run training. Spain and Portugal are catching up. If your country has limited access, a hybrid option is to combine a positional therapy vest plus a low-cost device while you queue for a custom MAD fitting.

3. Back2Sleep nasal stent: the best EU value at €39

The Back2Sleep starter kit is a CE-certified Class I medical nasal stent — a soft silicone tube inserted through one nostril to keep the nasal airway and rear pharynx open during sleep. It targets a frequently missed cause: nasal valve and upper airway collapse, which contributes to snoring in roughly half of habitual snorers, according to a 2022 European Rhinology study. It works on the first night for most users.

Why the value pick at €39: no prescription, same-day shipping across the EU, four sizes (XS/S/M/L) in the starter kit so you can find the right fit, and a 30-day money-back policy. Independent published evidence supports nasal stents for snoring and mild-to-moderate OSA, with reported AHI reductions of 30 to 50 percent in suitable candidates. It is not for severe OSA or central apnea. Insurance reimbursement is not part of the proposition — the price is low enough that out-of-pocket purchase is straightforward for most EU households. Read more about how nasal stents work if you want the science.

Why we rank Back2Sleep #3 and not #1

Pure transparency: we placed Back2Sleep at #3, not #1, because CPAP and custom mandibular advancement remain the higher-evidence interventions for diagnosed moderate-to-severe OSA. Where Back2Sleep wins decisively is on accessibility and value: CE-certified medical device, €39 entry price, 4 sizes for fit testing, no prescription, no electricity, no tubing, no monthly cost. For the very large group of European adults with primary snoring or mild OSA who would never start CPAP and cannot easily afford a €1,500 custom mandibular device, the nasal stent occupies an obvious gap.

Practically: most users find their best fit within the first week, replace the stent every 2 to 4 weeks of nightly use, and continue indefinitely or step down to occasional travel use. For the handful of users who do not respond, the 30-day return policy avoids stranded spend. Read about your first night with a nasal stent for what to expect.

4. Positional therapy: free-to-cheap and underused

Positional snoring describes snoring or apnoea events that occur mainly when sleeping on the back. About 50 percent of habitual snorers are positional, according to a 2023 Belgian sleep clinic registry. Positional therapy uses a chest or back-worn device that vibrates or physically prevents back-sleeping. The Philips NightBalance vest (CE-marked) and the Somnibel sensor (Spanish, EU-distributed) are the most studied EU options.

A 2024 European Respiratory Journal randomized trial reported AHI reduction of 38 percent in positional patients using NightBalance, with 6-month adherence above 80 percent — much higher than CPAP. Lower-tech alternatives work too: tennis balls in a back pocket, body pillows (€20 to €60), or wedge pillows. Positional therapy is also additive: combine with a nasal stent or MAD for compound benefit.

When positional therapy alone is enough

If a partner says you only snore on your back, and a smartphone snore-tracking night confirms it, side-sleeping enforcement may be enough. Otherwise, treat it as a free first-line addition rather than a standalone fix.

DIY positional therapy in 5 minutes

The cheapest experiment: pin a tennis ball into the back of an old t-shirt and sleep in it for two nights. If your partner confirms snoring is reduced and you feel less tired, you are positional. Upgrade to a body pillow or a NightBalance vest for sustainable nightly use. The European Sleep Research Society notes that combining positional enforcement with a nasal device can produce additive AHI reduction in roughly two-thirds of mild positional OSA patients.

5. Mouth tape: the viral trend with narrow indications

Mouth tape over closed lips encourages nasal breathing during sleep. Brands sold in the EU include SomniFix (CE-marked), Hostage Tape, and Dream Recovery. Trial data is thin but improving: a 2022 Otolaryngology study found a snoring index reduction of about 50 percent in mouth-breathers without nasal obstruction.

The catch: if your nose is blocked from valve collapse, polyps, deviated septum, or rhinitis, mouth tape will make things worse, not better. The European Academy of Otology has cautioned against blanket use without an ENT assessment. Cost is reasonable at €15 to €25 per month of disposable strips. For nasal-collapse snorers, a Back2Sleep stent or MAD is more appropriate than tape. Read about mouth taping safety before trying it.

6. Myofunctional therapy: tongue and throat exercises

Myofunctional therapy is daily tongue, soft-palate, and throat-muscle training, typically 10 to 20 minutes a day. A 2015 meta-analysis in Sleep showed 50 percent AHI reduction over 3 to 6 months in mild-to-moderate OSA. The European Academy of Orofacial Myology (EAOM) trains certified therapists across France, Italy, Germany, Spain, and the UK.

EU sessions cost €60 to €120 each, with full programs €200 to €800. The advantage is durability — gains persist after the program ends. The disadvantage is patience: results need 3 to 6 months and rigorous home practice. Best paired with another method for the first months while muscle tone builds. Read more about myofunctional therapy for snoring for example exercises.

Sample exercises you can start tonight

• Tongue press. Push the tip of the tongue against the hard palate, hold 5 seconds, repeat 20 times.
• Soft-palate hum. Sustained "ng" sound for 30 seconds, twice a day.
• Cheek puff. Inflate cheeks against closed lips, hold 5 seconds, 10 reps.
• Vowel calls. Loud articulation of A-E-I-O-U for 3 minutes daily.

None of these will fix snoring overnight. Together, daily, for 3 months, they meaningfully strengthen the muscles that hold the airway open during deep sleep. EU studies show the largest gains in adults with mild OSA and otherwise good baseline anatomy.

7. Weight loss: causal therapy for the right candidate

Visceral fat, particularly around the neck and tongue base, narrows the upper airway. A 2014 Sleep study showed a 10 percent body-weight reduction yields a 26 percent AHI reduction on average. Newer GLP-1 agonist therapy (Wegovy and the tirzepatide products Mounjaro and Zepbound) can produce 15 to 22 percent weight loss in 12 to 18 months and is now EMA-approved in many EU countries for obesity-related OSA.

Weight loss is not a quick fix for tonight, but if your BMI is over 28 and snoring started after weight gain, this is the most disease-modifying option. Pair with a short-term device for the months before weight loss takes effect. EU monthly costs for tirzepatide are €280 to €340 out of pocket; Wegovy similar. National reimbursement for obesity is patchy across Europe and tightening up only slowly. For most readers, expect to pay privately at first.

Non-pharmacologic weight loss

Mediterranean-style nutrition and 150 minutes per week of moderate cardio remain the cheapest intervention. The 2024 Lancet Diabetes & Endocrinology review of obesity-related OSA confirms that a sustained 8 to 10 percent body-weight reduction by lifestyle alone produces measurable AHI improvement in roughly half of obese OSA patients. The challenge is sustaining the loss; this is where GLP-1 therapy has changed expectations.

8. Anti-snore pillows and wedges: cheap baseline support

Anti-snore and wedge pillows raise the head and shoulders to reduce airway collapse and discourage back-sleeping. Smart pillows like the Motion Pillow (sold in the EU through select retailers) detect snoring acoustically and inflate sections to nudge the sleeper. Evidence is modest. A 2021 ENT review reported a 15 to 25 percent snoring index reduction with wedge pillows alone.

EU prices range from €30 (basic wedge) to €200 (smart pillows). Best used as a baseline addition rather than a standalone fix. Pair with positional therapy or a nasal stent for compounded benefit.

9. External nasal strips: the entry-level option

External adhesive nasal strips (Breathe Right, Nozovent) pull the outer nostrils outward to widen the external nasal valve. They help only the small subset of snorers whose obstruction is at the external valve, perhaps 15 percent of habitual snorers. EU price is low at €4 to €15 per pack. The 2024 ENT consensus rates them as effective only for the right candidate and recommends an internal device, like a nasal stent, when external collapse is not the issue.

For travel, costume parties, or one-off nights, strips are convenient. For consistent nightly use across years, a reusable internal stent is more economical and more effective for nasal-collapse snorers.

10. Smart beds and adjustable bases (EU models)

Smart beds with anti-snore detection automatically tilt the head section when snoring is detected. EU-available models include Tempur Pro Smartbase, Eight Sleep Pod (now shipping to EU through Eight Sleep Europe), and Hülsta Smart frames. A 2023 sleep technology review reported 40 to 60 percent snoring index reduction in positional snorers, similar to a dedicated positional therapy vest.

EU prices are steep: €2,500 to €8,000 depending on model and frame. Worth considering if you are buying a new bed anyway and a partner wants integrated snore mitigation. Not cost-effective as a standalone snoring fix.

What smart beds do well, and what they do not

Smart beds excel at automatic positional management — gently tilting you to a different angle when snoring starts so the partner is not woken up. They do not address the underlying obstruction. A snoring nasal-collapse sleeper on a smart bed will snore less but still snore. Combine a tilting base with a Back2Sleep nasal stent and you target both the position and the obstruction. Eight Sleep also offers temperature regulation that some users find improves total sleep time, which is a separate benefit.

11. Soft-palate, nasal, and orthognathic surgery

Surgery in 2026 is rarely first-line. Procedures in Europe include septoplasty for deviated septum (€2,500 to €4,500), turbinate reduction, soft-palate radiofrequency, uvulopalatopharyngoplasty (UPPP), and orthognathic / maxillomandibular advancement (MMA) for severe cases. UPPP has fallen out of favour due to mediocre long-term effect and side effects on swallowing.

MMA remains the most effective surgical option for severe OSA, with reported AHI reduction above 80 percent in suitable candidates. EU costs run €15,000 to €25,000 in private clinics or via specialised public hospital pathways. Recovery is 4 to 8 weeks. Reserved for younger patients with anatomical reasons surgery is likely to succeed.

12. Lifestyle: alcohol, sleep hygiene, allergies

Alcohol within 4 hours of bed dramatically worsens snoring by relaxing throat muscles. Late dinners, sleeping pills, and antihistamines do similar things. Allergic rhinitis (dust mites, pet dander, pollen) inflames the nasal mucosa and amplifies obstruction. Treating allergies with intranasal steroids (Avamys, Flixonase, Mometasone in the EU) can sharply reduce snoring in allergic patients.

Lifestyle is the cheapest, most universally applicable layer. It is also the easiest to ignore. Read our sleep hygiene checklist for the full list of free interventions worth running for two weeks before paying for any device.

The 14-night lifestyle baseline

• No alcohol within 4 hours of bed.
• Last meal at least 3 hours before bed.
• Side-sleeping on a body pillow or with a tennis ball pinned to your back.
• Bedroom temperature 17–19°C.
• No sleeping pills or antihistamines unless prescribed for another reason.
• Daily 30-minute brisk walk to support natural weight stability.
• Treat allergic rhinitis with antihistamine and intranasal steroid if seasonal symptoms.

Run this checklist for 14 nights before spending money on hardware. About a third of mild snorers improve enough on this baseline that no device is needed. The other two-thirds get a clearer picture of which underlying cause remains and what device should target it.

What does NOT work (despite the marketing)

Several heavily marketed snoring products do not have the evidence to back the claims. Save your money.

• Anti-snoring rings. Sold as acupressure devices for the little finger. No randomised trial evidence in adults.
• Anti-snoring bracelets / wristbands. Marketed as biofeedback to nudge position. Effect size is negligible in published data.
• Essential oil sprays. Decongestion may help allergy snorers transiently. No structural effect on airway.
• Magnetic patches. No mechanistic basis. Avoid.
• "Smart" earplugs that vibrate when partner snores. Help the partner sleep but do not treat the snorer.
• Fad mouth strips with no medical certification. Use only CE-marked SomniFix or equivalent if you intend to mouth-tape, and only after confirming clear nasal breathing.

The European Consumer Centre Network periodically reviews snoring product complaints. The pattern is consistent: untested gadgets purchased on marketplaces, no measurable effect on snoring volume, and no return options. Stick to CE-certified medical devices, evidence-backed dental work, or low-cost lifestyle interventions.

What about combining two devices?

Stacking devices can compound benefit when each targets a different obstruction site. Common evidence-backed pairs:

• Nasal stent + positional vest. Targets nasal airway plus back-sleeping. Compatible, low cost, broadly recommended for mild OSA.
• Mandibular device + nasal stent. Targets jaw retrusion plus nasal collapse. Works for some, awkward for others. Try one at a time first.
• CPAP + weight loss therapy. Allows lower CPAP pressures over time. Standard EU sleep medicine practice.
• Smart bed + mandibular device. Position management plus jaw advancement. Useful for couples where one partner is a positional snorer.

The downside of stacking is added complexity: more steps before bed, more failure points, and more chance of one element becoming a permission to skip the others. Keep stacks as simple as possible. Most snorers do well with two layers, not five.

How to choose: a 5-minute decision tree

Most adults benefit from a combination — for example, a nasal stent plus side-sleeping plus alcohol reduction. Single-method thinking is the trap. Start cheapest and most reversible. Step up only if needed.

Combination therapy: the strategy most snorers should run

The most effective real-world plan for chronic snorers and mild OSA is rarely a single device. It is layered. EU sleep clinics increasingly recommend combining 2 to 3 low-friction interventions for compounded benefit: positional therapy + nasal device, or weight loss + custom mandibular device, or CPAP + alcohol reduction. The 2024 ESRS consensus calls this "personalised stacking", and randomized trials report 20 to 40 percent better outcomes than any single intervention used alone.

An example stack a typical mild OSA patient might run: side-sleeping enforcement, nightly Back2Sleep nasal stent, no alcohol after 19:00, and a wedge pillow. Cost: under €100 total. Time to effect: same night. Reversible: completely. If after 30 nights the partner still reports loud snoring or you still feel unrefreshed, escalate to a sleep study and consider custom MAD or CPAP based on the result. This stepped approach matches AASM and ESRS 2026 guidance.

What to combine — and what not to combine

• Combine well. Nasal stent + positional therapy. Mandibular device + sleep hygiene. CPAP + weight loss.
• Combine cautiously. Mandibular device + nasal stent (works for some, awkward for others — try one at a time first).
• Do not combine. Mouth tape + blocked nose. Smart bed + snoring while drinking heavily and expecting it to fix everything.

Country availability: where to buy these in Europe

Most of the 12 methods are available in some form across the EU, but distribution varies. Here is a quick country snapshot for 2026 based on EU Medical Device Regulation (MDR) registers and major distributor catalogues.

For nasal stents, the key check is CE marking. Look for "CE-certified Class I medical device" wording on the product page. Cheap unbranded stents on marketplaces are often unregulated imports and can be unsafe.

Three real EU snorer profiles and what worked for them

The following case profiles are composites drawn from EU sleep clinic case series, anonymised for typical patient journeys. They illustrate how the 12-method ranking translates to real choices.

Profile 1: 42-year-old, BMI 27, frequent business traveller

Loud snoring noted by partner, self-reports blocked nose at night, no diagnosed OSA. Tried external nasal strips with limited effect. Stack that worked: lifestyle baseline (no alcohol Sun–Thu), Back2Sleep nasal stent nightly, side-sleeping on body pillow. Outcome at 3 months: partner reports near-silent sleep on hotel beds, daytime fatigue substantially improved. Total spend: under €120.

Profile 2: 56-year-old, BMI 32, diagnosed moderate OSA, CPAP intolerant

AHI 22 on home sleep test. Quit CPAP after 4 months due to mask discomfort. Stack that worked: started tirzepatide via private endocrinology, custom mandibular device fitted over 6 weeks, bedroom alcohol elimination. Outcome at 12 months: 12 percent weight loss, AHI re-test at 8, partner reports very mild snoring. Total spend: device €1,500, drug €280/month.

Profile 3: 35-year-old, BMI 22, primary snorer with deviated septum

Mild snoring worsened in last 5 years. ENT confirmed mild septal deviation but did not recommend surgery. Stack that worked: Back2Sleep starter kit (size M after fit testing all 4), nightly use, treated seasonal allergies with intranasal corticosteroid. Outcome at 6 weeks: partner says snoring is no longer audible. Total spend: €39 + €15 monthly steroid spray.

None of these required CPAP. None required surgery. All three followed the same strategy: identify obstruction site, layer 2 to 3 low-friction interventions, re-evaluate at 4 to 12 weeks. This is the practical pathway most EU snorers can run themselves with minimal clinic visits.

Where Back2Sleep fits in 2026

The 12-method analysis returns one consistent verdict: there is no single winner, only the right tool for your obstruction. The Back2Sleep nasal stent earns the best EU value position because it is the cheapest medical-grade option that addresses the most common missed cause (nasal collapse), works the first night, and ships across the EU with no prescription. It is not a CPAP replacement for severe OSA. It is the right starting point for snorers who breathe through the mouth at night, frequent travellers who hate tubing, and CPAP-intolerant adults with mild-to-moderate disease.

If you suspect OSA rather than primary snoring, take the sleep risk screening first and discuss results with your GP or sleep specialist. Snoring without OSA is annoying. Snoring with OSA is a cardiovascular risk factor, and you want a confirmed diagnosis before you choose the long-term plan. For our deeper guide to stop snoring tonight, see the linked article.

One last point on rankings. Research evolves. AD109 may make rank 7 obsolete by 2028 if EMA approves it. Genio and Inspire's price points may converge as competition intensifies. Custom mandibular devices may get cheaper as digital intraoral scanning democratises sleep dentistry. Watch the data, not the marketing. The ranking we publish today reflects the best 2026 evidence; expect us to update it annually as the EU sleep medicine evidence base develops.

Frequently asked questions

Frequently Asked Questions